Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of SW Louisiana LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern California Research Institute Medical Group Inc
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Blue Ridge Medical Research
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center, Digestive Health
mi
from
Topeka, KS
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Homestead Associates in Research Inc
mi
from
Homestead, FL
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Alzheimer's Research and Treatment Center
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Ochsner Health System
mi
from
New Orleans, LA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Summit Research Network
mi
from
Portland, OR
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CITRIALS
mi
from
Riverside, CA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Paradigm Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
CiTrials
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Safety and Efficacy of TRx0237 in Subjects With Early Alzheimer's Disease
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Roskamp Institute Clinic
mi
from
Sarasota, FL
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
Status: Enrolling
Updated: 12/31/1969
The Eye Institute of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lehigh Valley Hospital - Muhlenberg
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Pacific Gynecology Specialists
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Presbyterian Kaseman Hospital
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Alaska Women's Cancer Care
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
PeaceHealth Saint Joseph Medical Center
mi
from
Bellingham, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Charles Health System
mi
from
Bend, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Bismarck Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC-Boone
mi
from
Boone, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center-Einstein Campus
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Oncology Associates at Mercy Medical Center
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Regional Cancer System-Centralia
mi
from
Centralia, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Broadlawns Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Eureka
mi
from
Eureka, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC-Trinity Cancer Center
mi
from
Fort Dodge, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC-Marshalltown
mi
from
Marshalltown, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Novant Health Oncology Specialists-Mount Airy
mi
from
Mount Airy, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ochsner Medical Center Jefferson
mi
from
New Orleans, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Delaware Clinical & Laboratory Physicians, PA
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Methodist Hospital
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Illinois CancerCare - Peru
mi
from
Peru, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Saint Vincent Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Bon Secours Saint Mary's Hospital
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Nanticoke Memorial Hospital
mi
from
Seaford, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Cancer Center-Oncology Clinic
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Outpatient Center-Sunset Hills
mi
from
Sunset Hills, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Luke's Mountain States Tumor Institute-Twin Falls
mi
from
Twin Falls, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Saint Mary Regional Cancer Center
mi
from
Walla Walla, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Lexington Medical Center
mi
from
West Columbia, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rice Memorial Hospital
mi
from
Willmar, MN
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Cleveland Eye Clinic
mi
from
Brecksville, OH
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Kugler Vision, PC
mi
from
Omaha, NE
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Alterman, Modi and Wolter
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Ophthalmology Clinical Trial
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
Status: Enrolling
Updated: 12/31/1969
Vance Thompson Vision
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Pembrolizumab in Treating Participants With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of PT2977 in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
MedStar Health Research Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Chula Vista Cardiac Center
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Missouri Cardiovascular Specialists
mi
from
Columbia, MO
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Heart Failure Clinical Trial
Personalized CRT - MPP Post Approval Study
Status: Enrolling, Phase
Updated: 12/31/1969
Geisinger Wyoming Valley Medical Center
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
Iron Deficiency Anemia Clinical Trial
A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
O'Fallon, MO
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
Refractory Major Depressive Disorder Clinical Trial
A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Solid Tumors Clinical Trial
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Moffit Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling, Phase II
Updated: 12/31/1969
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Enrolling, Phase II
Updated: 12/31/1969
21st Century Neurology
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
Status: Enrolling, Phase II
Updated: 12/31/1969
Total Skin and Beauty Dermatology Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Psoriasis Clinical Trial
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
Status: Enrolling, Phase II
Updated: 12/31/1969
Dermatology Research Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Research of North Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Atlanta, GA
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Aurora, CO
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Cleveland, OH
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Louisville, KY
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Jacksonville Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Piedmont Heart Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
St. Luke's Idaho Cardiology Associates
mi
from
Boise, ID
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Sparrow Clinical Research Institute
mi
from
Lansing, MI
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Arrhythmia Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Aspirus Research Institute
mi
from
Wausau, WI
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Medical Research, LLC
mi
from
Willoughby, OH
Click here to add this to my saved trials
Paroxysmal Supraventricular Tachycardia Clinical Trial
Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302
Status: Enrolling, Phase III
Updated: 12/31/1969
Cardiology Consultants of Philadelphia
mi
from
Yardley, PA
Click here to add this to my saved trials
Atrial Fibrillation Clinical Trial
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
Status: Enrolling, Phase
Updated: 12/31/1969
Saint Luke's/ Mid-America Heart Institute
mi
from
Kansas City, MO
Click here to add this to my saved trials